Adamas Pharmaceuticals
ADMS
#7086
Rank
โ‚ฌ0.35 B
Marketcap
7,81ย โ‚ฌ
Share price
0.00%
Change (1 day)
16,846.62%
Change (1 year)

Revenue for Adamas Pharmaceuticals (ADMS)

Revenue in 2021 (TTM): โ‚ฌ74.33 Million

According to Adamas Pharmaceuticals 's latest financial reports the company's current revenue is โ‚ฌ83.74 Million. In 2020 the company made a revenue of โ‚ฌ70.71 Million an increase over the revenue in the year 2019 that were of โ‚ฌ51.88 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adamas Pharmaceuticals from 2013 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚ฌ74.33 M5.12%
2020โ‚ฌ70.71 M36.28%
2019โ‚ฌ51.88 M60.48%
2018โ‚ฌ32.33 M
2016โ‚ฌ0.54 M-70.15%
2015โ‚ฌ1.81 M-96.57%
2014โ‚ฌ53.03 M-21.45%
2013โ‚ฌ67.51 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ77.57 M-7.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.59 B 614.56%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ52.23 B 62,266.05%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ38.22 B 45,543.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ59.33 B 70,746.70%๐Ÿ‡บ๐Ÿ‡ธ USA